A new ven­ture fund amid a pan­dem­ic? In the Nordics? Eir Ven­tures brings it on with €76M first close

From Phar­ma­cia and Lund­beck to No­vo Nordisk and As­traZeneca, the Nordic coun­tries have been the birth­place for some lega­cy phar­ma com­pa­nies. But for all that his­to­ry and rep­u­ta­tion, Stephan Christ­gau counts on­ly five spe­cial­ized life sci­ence in­vestors back­ing biotechs to­day.

That leaves plen­ty of room for Eir Ven­tures, a brand new ven­ture fund Christ­gau — one of the founders of No­vo Seeds — is launch­ing with three oth­er vet­er­an VCs.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER